Skip to main content
Fig. 1 | Breast Cancer Research

Fig. 1

From: CD105+ fibroblasts support an immunosuppressive niche in women at high risk of breast cancer initiation

Fig. 1

CD105+ fibroblasts are more abundant in cultures from older women and women with BRCA1 mutations. A Flow cytometry measurement of CD105 proportion in fibroblasts from women ranging from 16 to 70 years of age (n = 20); simple linear regression plotted with 95% confidence intervals. B Flow cytometry measurement of CD105 proportion in fibroblasts from age-matched women with varying BRCA1 mutational status (AR n = 13, BRCA1mut/+ n = 10); unpaired t test with Welch’s correction (P value = 0.026). C Population doublings of CD105+ and CD105- fibroblasts from women with different BRCA1 mutational statuses in serial passage subculture, error bars represent standard deviation, two-way ANOVA (**** = P < 0.0001)

Back to article page